Hong Kong-listed company IVD Medical Holding Limited announced plans to seek approval from a special shareholders' meeting to authorize the board to purchase cryptocurrencies not exceeding HKD 3 billion within the next 36 months, primarily Ethereum (ETH).
The company stated that this move aims to solidify the ETH reserve fund and accelerate the ecological construction of the ivd.xyz exchange. The relevant cryptocurrencies will be purchased through regulated platforms such as HashKey Exchange, with funding sources including the company's idle cash and potential fundraising. This time, the single purchase premium will not exceed 10%, and a dedicated risk control team has been established to manage risks.